These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 12548563)

  • 1. Outer membrane protein A renders dendritic cells and macrophages responsive to CCL21 and triggers dendritic cell migration to secondary lymphoid organs.
    Jeannin P; Magistrelli G; Herbault N; Goetsch L; Godefroy S; Charbonnier P; Gonzalez A; Delneste Y
    Eur J Immunol; 2003 Feb; 33(2):326-33. PubMed ID: 12548563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes.
    Hirao M; Onai N; Hiroishi K; Watkins SC; Matsushima K; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Apr; 60(8):2209-17. PubMed ID: 10786686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania major modulates chemokine and chemokine receptor expression by dendritic cells and affects their migratory capacity.
    Steigerwald M; Moll H
    Infect Immun; 2005 Apr; 73(4):2564-7. PubMed ID: 15784607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties.
    Sozzani S; Allavena P; D'Amico G; Luini W; Bianchi G; Kataura M; Imai T; Yoshie O; Bonecchi R; Mantovani A
    J Immunol; 1998 Aug; 161(3):1083-6. PubMed ID: 9686565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory effects of vasoactive intestinal peptide on the migration of mature dendritic cells.
    Weng Y; Sun J; Wu Q; Pan J
    J Neuroimmunol; 2007 Jan; 182(1-2):48-54. PubMed ID: 17081624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytomegalovirus inhibits the migration of immature dendritic cells by down-regulating cell-surface CCR1 and CCR5.
    Varani S; Frascaroli G; Homman-Loudiyi M; Feld S; Landini MP; Söderberg-Nauclér C
    J Leukoc Biol; 2005 Feb; 77(2):219-28. PubMed ID: 15522919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation.
    Yanagihara S; Komura E; Nagafune J; Watarai H; Yamaguchi Y
    J Immunol; 1998 Sep; 161(6):3096-102. PubMed ID: 9743376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential responsiveness to constitutive vs. inducible chemokines of immature and mature mouse dendritic cells.
    Vecchi A; Massimiliano L; Ramponi S; Luini W; Bernasconi S; Bonecchi R; Allavena P; Parmentier M; Mantovani A; Sozzani S
    J Leukoc Biol; 1999 Sep; 66(3):489-94. PubMed ID: 10496320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paired synovium and lymph nodes from rheumatoid arthritis patients differ in dendritic cell and chemokine expression.
    Page G; Miossec P
    J Pathol; 2004 Sep; 204(1):28-38. PubMed ID: 15307135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR and CC chemokine expression in relation to Flt3 ligand-induced renal dendritic cell mobilization.
    Coates PT; Colvin BL; Ranganathan A; Duncan FJ; Lan YY; Shufesky WJ; Zahorchak AF; Morelli AE; Thomson AW
    Kidney Int; 2004 Nov; 66(5):1907-17. PubMed ID: 15496162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of CCL19 by DC-Lamp+ mature dendritic cells in human lymph node versus chronically inflamed skin.
    Katou F; Ohtani H; Nakayama T; Nagura H; Yoshie O; Motegi K
    J Pathol; 2003 Jan; 199(1):98-106. PubMed ID: 12474232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-kappaB pathways.
    Liu Q; Chen T; Chen G; Shu X; Sun A; Ma P; Lu L; Cao X
    Mol Immunol; 2007 Apr; 44(10):2686-96. PubMed ID: 17223196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL21 is sufficient to mediate DC migration, maturation and function in the absence of CCL19.
    Britschgi MR; Favre S; Luther SA
    Eur J Immunol; 2010 May; 40(5):1266-71. PubMed ID: 20201039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma dose-dependently inhibits prostaglandin E2-mediated dendritic-cell-migration towards secondary lymphoid organ chemokines.
    Alder J; Hahn-Zoric M; Andersson BA; Karlsson-Parra A
    Vaccine; 2006 Nov; 24(49-50):7087-94. PubMed ID: 16889876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human monocyte-derived dendritic cells expressing both chemotactic cytokines IL-8, MCP-1, RANTES and their receptors, and their selective migration to these chemokines.
    Zhu K; Shen Q; Ulrich M; Zheng M
    Chin Med J (Engl); 2000 Dec; 113(12):1124-8. PubMed ID: 11776150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages.
    Kaufmann A; Salentin R; Gemsa D; Sprenger H
    J Leukoc Biol; 2001 Feb; 69(2):248-52. PubMed ID: 11272275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells.
    Marsland BJ; Bättig P; Bauer M; Ruedl C; Lässing U; Beerli RR; Dietmeier K; Ivanova L; Pfister T; Vogt L; Nakano H; Nembrini C; Saudan P; Kopf M; Bachmann MF
    Immunity; 2005 Apr; 22(4):493-505. PubMed ID: 15845453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells.
    Kellermann SA; Hudak S; Oldham ER; Liu YJ; McEvoy LM
    J Immunol; 1999 Apr; 162(7):3859-64. PubMed ID: 10201903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pivotal role for CC chemokine receptor 5 in T-cell migration to tumor sites induced by interleukin 12 treatment in tumor-bearing mice.
    Uekusa Y; Yu WG; Mukai T; Gao P; Yamaguchi N; Murai M; Matsushima K; Obika S; Imanishi T; Higashibata Y; Nomura S; Kitamura Y; Fujiwara H; Hamaoka T
    Cancer Res; 2002 Jul; 62(13):3751-8. PubMed ID: 12097285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL19-IgG prevents allograft rejection by impairment of immune cell trafficking.
    Ziegler E; Gueler F; Rong S; Mengel M; Witzke O; Kribben A; Haller H; Kunzendorf U; Krautwald S
    J Am Soc Nephrol; 2006 Sep; 17(9):2521-32. PubMed ID: 16899521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.